About Us

David Passov, MBA

CEO

David Passov boasts extensive leadership experience in life sciences and clinical research, having successfully led large-scale operations and strategic growth initiatives across global markets. David was born in Estonia and attended Tartu University Medical School before moving to the US in 1993. He earned a biology degree from Boston College and worked in basic science research at Massachusetts General Hospital before entering the biopharmaceutical industry in 1996. Over the years, David has held various roles in clinical operations, project management, business development, and general management at several CROs. He received an MBA from Northeastern University in 2002.

In 2005, David joined ClinStar, where he became CEO in 2019, leading the company through its acquisition by PRA Health Sciences in 2013. He then served as Head of Project Management for the EAPA region and later as Senior VP of Strategic Advisory at PRA/ICON until his retirement in April 2024. David is currently based in the UK and has been living there for the past nine years.

Martijn van de Leur – MSc

Martijn van de Leur is a senior leader with close to two decades of experience in the fields of pharmacovigilance, regulatory affairs and medical information. After 15 years in large international pharma companies, Martijn joined Biomapas as Head of Global Pharmacovigilance in early 2020. Martijn has a broad network within the industry and is a known speaker with excellent cross-functional pharma industry experience. Before joining Biomapas, he held several executive roles as (Deputy) EU QPPV, Global Head of Drug Safety Compliance and Global Head of Drug Safety Technologies at Vifor Pharma in Switzerland, and further back in his career working as Pharmacovigilance Lead at Merck Sharp & Dohme in The Netherlands.

Filip Risteski – ACCA

Filip Risteski is a finance professional who has diverse experience throughout his career. He was working in a professional services company as a senior manager for 11 years while providing assurance and advisory business services in different sectors such as financial, public, insurance, transport, retail, manufacturing, oil & gas, pharma and others. Filip’s professional experience extends to leading multi-country projects involving BIG4 Companies not only in the Baltics but also in the East, North, Central zones of Europe and also the UK and the US.

In addition to audit and finance expertise, Filip has experience in different fields such as recruitment, employee learning & development, lecturing on various finance-related topics, business valuation, tax & legal compliance, business development and resource management. Filip holds a degree in Business Administration, has ACCA accreditation since 2004 and is fluent in 5 languages.

Agata Bloswick

Chief Clinical Research Operating Officer

Agata has been working in the clinical research industry for over 20 years. She has led project delivery, start-up, regulatory and clinical operations in clinical trials, and is passionate about leveraging technology to streamline processes and expanding geographic diversity to deliver equitable healthcare services.

Egidija Paurienė – MD

Egidija Pauriene, MD, manages and ensures quality systems. She helps guide the integration of the corporate strategies of Biomapas Group related to GxP Quality Assurance, regulatory compliance, including Good Pharmacovigilance Practice and ISO 9001:2015 standards. She has conducted and supervised GxP audits, as well as audits to CROs, and Suppliers. Edigija is a member of Research Quality Assurance, Investigator GCP trainer, Member of Society of Infectologist.

Lina Dapkutė

Head of People & Office Management

Lina Dapkute is a seasoned Human Resources professional with over 15 years of experience across diverse industries, including manufacturing, energy, and retail. Her expertise spans HR processes such as learning and development, talent management, succession planning, compensation, and performance management. Lina has successfully led initiatives in leadership development, employee engagement, and organizational transformation. Since joining Biomapas in 2022, she has been instrumental in advancing HR strategies and fostering a people-centric organizational culture.

Evelina Davidonienė – MPharm

Evelina has over 15 years of experience in regulatory affairs. She has extensive knowledge of the regulatory environment and deep expertise in regulatory strategies, external engagement, and advocacy activities.

Before joining Biomapas, she drove teams in senior leadership positions at GSK. However, her strong understanding of compliance, quality, and market access has led her to a head of regulatory affairs operations role at Biomapas, where she excels as a passionate, communicative leader with an orientation for results, positive change and team growth.

Olga Asimaki – CMD, PhD.

Olga Asimaki is a certified Medical Affairs professional with extensive experience in all aspects of Pharmacovigilance and Medical Information. Olga is a post-doctoral Neuroscientist holding an MSc from King’s College London and a PhD in Pharmacology. Before joining Biomapas, Olga was Head of Pharmacovigilance and Medical Information at AbbVie, leading and developing pharmacovigilance/medical information teams and systems. During her career, she has worked with global teams to successfully launch, implement and maintain a global medical information system and its processes.

Albert Bekfi – MSc

Albert is a pharmacovigilance expert with over 11 years of experience in the field. He has vast experience in different pharmacovigilance operations, from literature monitoring, vendor management, global and local case processing oversight, to safety database management. Before joining Biomapas, Albert held several strategic pharmacovigilance roles in various outsourcing service providers. He has extensive leadership experience in the pharma industry, which led him to become the Head of Pharmacovigilance Operations at Biomapas.

Irma Ušinskienė – BSc

Irma Usinskiene has been in the Clinical Research field for over 14 years. She has extensive experience in different roles, including leading Eastern Europe clinical study teams in phase II-IV clinical trials in various indications.

In 2015 she joined Biomapas for Clinical Research Manager role with line management responsibilities, ensuring high-quality performance. Since then, Irma has developed her experience in people management and team leadership. Currently, she is leading the Clinical Operation Managers’ team.

Indrė Dryžienė – MBI

Indre Dryziene has strong expertise in Clinical Trials, with over 12 years of experience in the CRO setting and management of clinical research activities across the European and CIS markets. As an experienced business professional, Indre was involved in the business development and strategic management of Biomapas. Over the last 10 years, she held various positions, such as a Managing Director and Member of the Board. Indre holds a Master Degree in Business Information Technologies. On top of it, she is certified in Strategic Management and Marketing Strategy from ISM University of Management and Economics.

Alexander Winterling

Chairman of the Board

Alexander started in investment banking and later embarked on an entrepreneurial path at a Swiss multinational in restructuring and growth roles in China and Europe. Throughout his carrer he invested in and developed a leading health-tech scale-up. He holds a Diploma from the University of St. Gallen.

Audrius Sveikata, MD, PhD. – CEO

Audrius Sveikata has over 20 years of experience in clinical research and regulatory affairs, holding executive positions within competent authorities, academia, pharmaceutical industry, and professional associations. His expertise includes the design and implementation of clinical development plans and regulatory strategies in the EU. Before co-founding CRO Biomapas, Audrius was Head of Clinical Assessors unit at State Medicines Control Agency of Lithuania. As a pharmacology professor at the Lithuanian University of Health Sciences, Audrius was involved in teaching and science with a neuro-psychopharmacology specialization. He is active as a lecturer in various life science conferences, a co-author of over 50 scientific publications.

Dr. Markus Petersen, PhD

Board Member

Markus started in private equity and later switched to an operational role. During the last 10 years he served in CFO roles for PE backed firms in buy-and-build, restructuring and strategic refocusing situations. He holds a Diploma and a PhD from EBS Business School.

Aileen Fisher – MBA

Aileen is a senior executive and leader with more than 25 years in the Pharmaceutical and Life Sciences sector. She is an effective change agent who is proven in department set up, restructuring and transformation through growth or retraction of teams and is known for identifying and resolving problems in organisation, structure and process. Aileen is an effective business leader with a strong commercial understanding. Aileen is a registered pharmacist in the UK and a member of The Organisation for the Profession of Regulatory Affairs (TOPRA), where she acted as a Board member for 4 years and won the 2021 TOPRA award for Inspiration. Aileen completed an executive MBA from the University of Cambridge in May 2022.

Petras Sveikata – BEc

Petras Sveikata has joined Biomapas as a Member of the Board in 2020. Petras has been involved in principal investing and investment banking since 2015. Before assuming the Principal’s role with the life sciences group Sveikata & CO, Petras was an Associate Director in the leading Baltic Investment Banking boutique Superia where he initially started as a 2nd-year analyst. While with Superia Petras participated in both M&A and capital raising transactions in various sectors with the most recent transaction being the acquisition of the largest Lithuanian private clinic MediCa and Kardiolita hospital chains completed in September 2020. Mr. Sveikata holds a Bachelor’s Degree in Economics from City University London.

Big Enough To Cover All Your Needs.
Small Enough To Care.

Discover how Biomapas provides all the support to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Reliable support for every phase of your clinical trial, from recruitment to results.

Pharmacovigilance

Flexible safety monitoring to keep your products compliant and trusted.

Regulatory Affairs

Confidently navigate regulatory challenges with expert support.

Medical Information

Clear, accurate medical information 24/7, tailored for global audiences.

About us

Careers

Academy

Insights

Talk to an expert

Biomapas

Your global outsourcing partner for Clinical Research, Pharmacovigilance, Regulatory Affairs and Medical Information.

At the heart of Biomapas. Always.

Values are how we shape our internal culture and environment, and they are all around us. You can find them in how we act and communicate, how we approach our clients and partners, and how we shape our company‘s future together.

B Partner

Demonstrate a client first approach in everything you do, making sure their needs are met.
Be flexible and ready to adjust your plans when things change, so you can meet the needs of stakeholders as they evolve.
Think ahead and find creative solutions to problems, making sure we always go above and beyond to keep our promises.
Take charge of your work and see it through to the end, always delivering on time and being honest and transparent about your actions.

B Leader

Transparently communicate both issues and progress, proactively share constructive feedback.
Demonstrate leadership through actions, lead by example not through words.
Be resilient by not giving up and finding alternative solutions in challenging situations.
Take responsibility for your decisions, actions and their consequences.
Focus on tasks that contribute to Biomapas’ success.

B Together

Be open to collaboration, develop teamwork skills, and remain flexible when working with others.
Maintain a positive, supportive attitude, notice and celebrate big and small achievements.
Show respect in every situation, be approachable for communication and demonstrate empathy and trust.
Be aligned with others, act with one voice.

We don‘t only know Biomapas’ values by heart when asked.
We live our values all the time.

Our Mission & Vision.

To combine the strength of our expertise, experience and high quality deliverables to advance clinical development, market access and post-approval support to the Pharmaceutical, Biotech and Medical Device industries, and ultimately improve health of patients. With more than two decades of experience, we tailor our services to your specific needs.

Through centralized governance and thorough quality control, we ensure full compliance with all national, international and global guidelines and regulations. As one of the fastest growing solution providers in the Central Eastern Europe, we pride ourselves in delivering client-oriented solutions, by quickly adapting to ever-changing environment.

Thanks to the passion, commitment, and quality we show our clients we form long-term partnerships.

Biomapas keeps increasing its geographical reach, range of services, and currently counts over 500 colleagues.

And a presence in over 60 countries across EU and the CIS, MENA, and EAEU region.

Our Leadership Team

David Passov, MBA

CEO

Martijn van de Leur, MSc

Chief Commercial Officer

Filip Risteski, FCCA

Chief Financial and Administrative Officer

Agata Bloswick

Chief Clinical Research Operating Officer

Egidija Paurienė, MD

Head of Quality Assurance

Lina Dapkutė

Head of People & Office Management

Our service delivery management team

Evelina Davidonienė, MPharm

Head of Global Regulatory Affairs Operations

Olga Asimaki, CMD, PhD.

International QPPV / Head of Global Medical Information.

Albert Bekfi, MSc

Head of Global Pharmacovigilance Operations

Irma Ušinskienė, BSc

Head of Clinical Operations

Indrė Dryzienė

Head of CO Project Management

Our Board

Alexander Winterling

Chairman of the Board

Audrius Sveikata, MD, PhD.

Board Member

Dr. Markus Petersen, PhD.

Board Member

Aileen Fisher, MBA

Board Member

Petras Sveikata, BEc

Board Member

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

David Passov, MBA

CEO

Martijn van de Leur – MSc

Filip Risteski – ACCA

Agata Bloswick

Chief Clinical Research Operating Officer

Egidija Paurienė – MD

Lina Dapkutė

Head of People & Office Management

Evelina Davidonienė – MPharm

Olga Asimaki – CMD, PhD.

Albert Bekfi – MSc

Irma Ušinskienė – BSc

Indrė Dryžienė – MBI

Alexander Winterling

Chairman of the Board

Audrius Sveikata, MD, PhD. – CEO

Dr. Markus Petersen, PhD

Board Member

Aileen Fisher – MBA

Petras Sveikata – BEc

Big Enough To Cover All Your Needs.Small Enough To Care.

Clinical Research

Pharmacovigilance

Regulatory Affairs

Medical Information

Biomapas

At the heart of Biomapas. Always.

B Partner

B Leader

B Together

Our Mission & Vision.

Thanks to the passion, commitment, and quality we show our clients we form long-term partnerships.

Biomapas keeps increasing its geographical reach, range of services, and currently counts over 500 colleagues.

And a presence in over 60 countries across EU and the CIS, MENA, and EAEU region.

Our Leadership Team

David Passov, MBA

Martijn van de Leur, MSc

Filip Risteski, FCCA

Agata Bloswick

Egidija Paurienė, MD

Lina Dapkutė

Our service delivery management team

Evelina Davidonienė, MPharm

Olga Asimaki, CMD, PhD.

Albert Bekfi, MSc

Irma Ušinskienė, BSc

Indrė Dryzienė

Our Board

Alexander Winterling

Audrius Sveikata, MD, PhD.

Dr. Markus Petersen, PhD.

Aileen Fisher, MBA

Petras Sveikata, BEc

Big Enough To Cover All Your Needs. Small Enough To Care.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information

Clinical Trials

PV System & QPPV

Post-Authorization

We value your privacy.

Big Enough To Cover All Your Needs.
Small Enough To Care.